CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 262 filers reported holding CLOVIS ONCOLOGY INC in Q3 2017. The put-call ratio across all filers is 0.57 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $123,000 | -73.3% | 103,638 | -59.4% | 0.00% | – |
| Q2 2022 | $460,000 | -25.1% | 255,383 | -15.9% | 0.00% | – |
| Q1 2022 | $614,000 | -48.4% | 303,691 | -30.9% | 0.00% | -100.0% |
| Q4 2021 | $1,191,000 | -61.1% | 439,429 | -36.0% | 0.00% | -50.0% |
| Q3 2021 | $3,062,000 | -19.4% | 686,704 | +4.9% | 0.00% | 0.0% |
| Q2 2021 | $3,797,000 | +71.6% | 654,762 | +107.7% | 0.00% | 0.0% |
| Q1 2021 | $2,213,000 | +55.5% | 315,309 | +6.4% | 0.00% | +100.0% |
| Q4 2020 | $1,423,000 | -46.8% | 296,405 | -35.3% | 0.00% | -50.0% |
| Q3 2020 | $2,673,000 | +54.5% | 458,464 | +78.9% | 0.00% | 0.0% |
| Q2 2020 | $1,730,000 | +467.2% | 256,213 | +230.6% | 0.00% | – |
| Q3 2019 | $305,000 | -75.8% | 77,511 | -8.6% | 0.00% | -100.0% |
| Q2 2019 | $1,260,000 | -40.2% | 84,763 | -0.2% | 0.00% | -50.0% |
| Q1 2019 | $2,107,000 | +47.8% | 84,909 | +6.9% | 0.00% | 0.0% |
| Q4 2018 | $1,426,000 | -45.6% | 79,428 | -11.0% | 0.00% | 0.0% |
| Q3 2018 | $2,621,000 | -36.2% | 89,226 | -1.2% | 0.00% | -50.0% |
| Q2 2018 | $4,105,000 | +20.6% | 90,270 | +40.1% | 0.00% | +33.3% |
| Q1 2018 | $3,403,000 | -22.4% | 64,437 | -0.1% | 0.00% | -25.0% |
| Q4 2017 | $4,385,000 | +13.9% | 64,478 | +38.0% | 0.00% | 0.0% |
| Q3 2017 | $3,850,000 | -13.2% | 46,716 | -1.4% | 0.00% | 0.0% |
| Q2 2017 | $4,436,000 | +922.1% | 47,385 | +595.2% | 0.00% | +300.0% |
| Q1 2017 | $434,000 | +65.6% | 6,816 | +15.6% | 0.00% | – |
| Q4 2016 | $262,000 | +29.7% | 5,898 | +5.5% | 0.00% | – |
| Q3 2016 | $202,000 | -96.0% | 5,593 | -89.7% | 0.00% | -100.0% |
| Q3 2015 | $4,993,000 | +0.6% | 54,296 | -3.9% | 0.01% | +14.3% |
| Q2 2015 | $4,963,000 | +19.4% | 56,475 | +0.9% | 0.01% | +16.7% |
| Q1 2015 | $4,156,000 | +33.4% | 55,981 | +0.6% | 0.01% | +20.0% |
| Q4 2014 | $3,115,000 | +23.3% | 55,630 | -0.1% | 0.01% | +25.0% |
| Q3 2014 | $2,526,000 | +9.0% | 55,695 | -0.5% | 0.00% | 0.0% |
| Q2 2014 | $2,317,000 | -40.1% | 55,955 | +0.2% | 0.00% | -42.9% |
| Q1 2014 | $3,867,000 | +15.3% | 55,821 | +0.3% | 0.01% | +16.7% |
| Q4 2013 | $3,354,000 | +14.6% | 55,644 | +15.6% | 0.01% | 0.0% |
| Q3 2013 | $2,926,000 | +5.8% | 48,144 | +16.6% | 0.01% | 0.0% |
| Q2 2013 | $2,766,000 | – | 41,302 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 150,000 | $1,564,000 | 4.60% |
| Healthcare Value Capital, LLC | 100,000 | $1,043,000 | 3.07% |
| Palo Alto Investors LP | 5,056,286 | $52,712,000 | 2.90% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,328,200 | $13,848,000 | 1.53% |
| Ikarian Capital, LLC | 513,700 | $5,355,000 | 0.87% |
| Pinz Capital Management, LP | 207,800 | $2,166,000 | 0.79% |
| Leap Investments LP | 146,300 | $1,525,000 | 0.72% |
| Elk Creek Partners, LLC | 574,616 | $5,990,000 | 0.69% |
| SECTOR GAMMA AS | 408,625 | $4,260,000 | 0.68% |
| Artal Group S.A. | 1,000,000 | $10,425,000 | 0.40% |